Pharmacists’ Role in Cardiovascular Disease Management in Saudi Arabia:A Systematic Review

Main Article Content

Riyadh Atitallah Alghanmy
Nawaf Attitallah Albeladi
Sabri Abdullah Alraigi
Abdulrahman Salem Alghamdi
Faisal Ahmed Alamari
Sultan Thawab Almutairi
Wafaa Obaid Albushri
Osama Mohammed Alsahafi
Mohammed Atiahallah Alghanmi
Ahmed Mohammed Saad Shuwaila

Abstract

Objective: The purpose of this review is to assess the extent of the professional activities of pharmacists with regards to cardiovascular disease (CVD) in Saudi Arabia with regard to patient care and medication management and health-related outcomes.


Methods: The current systematic review was performed according to the PRISMA statement. This was followed by a search in PubMed, Medline, and Google Scholar using the following search terms; cardiovascular disease, pharmacist intervention as well as Saudi Arabia.


Results: The results help to determine that the practical activities involving pharmacists, medication management and adherence, counseling and lifestyle interventions positively affect clinical outcomes including blood pressure and cholesterol levels. That there are some barriers to involvement of pharmacist which are; regulatory and patent awareness barriers.


Conclusion: New insight has been provided concerning the aspects of the role of pharmacists in management of CVD and the impact on patient’s clinical performance in Saudi Arabia. Improving such barriers can increase the impact of those recommendations even for the country’s healthcare agenda and for better population health by expanding integrated approaches to CVD management.


 

Article Details

Section
Articles